1) type 2 diabetic retinopathy
2型糖尿病视网膜病变
1.
Clinical research of relation of PEDF,TNF-α and adiponectin with type 2 diabetic retinopathy
PEDF,TNF-α及脂联素与2型糖尿病视网膜病变的临床研究
2) Diabetic retinopathy
糖尿病视网膜病变
1.
Treatment of diabetic retinopathy by combination of kallidinogenase and compound Danshen dripping pills;
胰激肽原酶与复方丹参滴丸联合治疗糖尿病视网膜病变的临床观察
2.
Chinese drugs combine with Duobeisi for diabetic retinopathy;
中药联合多贝斯治疗糖尿病视网膜病变临床研究
3.
Combined therapy for diabetic retinopathy after cataract extraction;
白内障术后糖尿病视网膜病变的综合治疗
3) diabetic retinopathy
糖尿病性视网膜病变
1.
Analysis of effects of laser photocoagulation for diabetic retinopathy;
激光光凝治疗糖尿病性视网膜病变疗效分析
2.
Susceptibility genes for diabetic retinopathy;
糖尿病性视网膜病变的易感基因(英文)
3.
Analysis of anterior ischemic optic neuro-pathy in patients with diabetic retinopathy;
糖尿病性视网膜病变患者前部缺血性视神经病变临床分析
4) diabetic retinopathy/metabolism
糖尿病视网膜病变/代谢
5) DR
糖尿病视网膜病变
1.
CDI evaluation DR treatment with using Xueshuantong complex capsule;
血栓通治疗糖尿病视网膜病变的眼血流动力学超声多普勒检测评估
2.
Objective: By the analysis of the syndrome differentiation of viscera about diabetes mellitus(DM) and the relationship between DR and the other factors,we tried to find out the developing rule and the intrinsical interrelated viscera about DR, new ideas and therapies were afforded on the prevention and treatment of DR accordingly.
目的:通过分析糖尿病的中医脏腑辨证分型,研究糖尿病视网膜病变(DR)的中医证候特点及相关发病因素,探讨DR发生、发展的基本演变规律,以及与脏腑病变的内在联系,为DR的早期预防及治疗提供新方法和新思路。
3.
DR is the primary cause to grow .
糖尿病性视网膜病变(Diabetic Retinopathy,DR)是糖尿病全身并发病中最为严重的微血管病变之一,是糖尿病的眼底微血管并发症,新生血管形成是糖尿病视网膜病变病情进一步加重的主要标志。
6) diabetes retinopathy
糖尿病视网膜病变
1.
Treating the Diseases in terms of Liver,Spleen and Kidney,Principle of Treatment is Nourishing Yin and Expelling Blood Stasis ——professor Lin Lan′s experience in treatment of diabetes retinopathy;
著名中医学家林兰教授学术经验之十一 病位侧重肝脾肾 治宜祛瘀重养阴——治疗糖尿病视网膜病变的经验
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条